Nadia Khan
Scientist, MD, M.SC.
Dr. Nadia Khan is a Clinician Scientist in the field of clinical epidemiology and health services research at CHÉOS and the University of British Columbia (UBC).
Research Interests
- Ethnic and gender differences in chronic disease incidence and outcomes
- Chronic disease prevention and management of Type 2 diabetes, hypertension, stroke, and cardiovascular disease
- Hypertension outcomes research
She is a specialist in internal medicine and a clinical specialist in hypertension by the American Society of Hypertension.
She was elected President of Hypertension Canada (2016-2020) and is the lead for the Research and Education Committee at the International Society of Hypertension.
Research areas of focus include investigation of cardiovascular risk factors and chronic disease prevention and management focusing on hypertension, in vulnerable populations including women and ethnic groups. Dr. Khan is completing a randomized controlled trial (Namaste Diabetes trial) to investigate culturally tailored interventions in the management of chronic cardiovascular disease and its risk factors in ethnic groups.
Publications of Note
Additional Affiliations
- Professor and Head, Division of General Internal Medicine, Department of Medicine, Faculty of Medicine, UBC
- Associate Member, School of Population and Public Health, UBC
Media Coverage
- Two-thirds of Vancouver hospital physicians feeling burnt-out, survey says (News 1130, June 2021)
- Obesity linked to social ties in older women, more so than in men (Medical Xpress, July 2020)
- What do I need to know about COVID-19 and blood pressure? Plus, when should I worry about my blood pressure? (The Dose CBC, March 2020)
- Episode 6: Ethnicity and Cardiovascular Diseases (Beats Research Radio, October 2019)
- Hypertension Canada releases list of recommended blood pressure devices (CTV News, April 2018)
